Evidence map›Paper›PMID 41169915›Full record

ArticleFrontiers in psychology2025

Clarifying the reliability paradox: poor measurement reliability attenuates group differences.

Povilas Karvelis, Andreea O Diaconescu

Abstract read
In one paragraph

Article in Frontiers in psychology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Povilas KarvelisKrembil Centre for Neuroinformatics, Centre for Addiction and Mental Health (CAMH), Toronto, ON, Canada.
Andreea O DiaconescuKrembil Centre for Neuroinformatics, Centre for Addiction and Mental Health (CAMH), Toronto, ON, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cognitive sciences are grappling with the reliability paradox: measures that robustly produce within-group effects tend to have low test-retest reliability, rendering them unsuitable for studying individual differences. Despite the growing awareness of this paradox, its full extent remains underappreciated. Specifically, most research focuses exclusively on how reliability affects correlational analyses of individual differences, while largely ignoring its effects on studying group differences. Moreover, some studies explicitly and erroneously suggest that poor reliability does not pose problems for studying group differences, possibly due to conflating within- and between-group effects. In this brief report, we aim to clarify this misunderstanding. Using both data simulations and mathematical derivations, we show how observed group differences get attenuated by measurement reliability. We consider multiple scenarios, including when groups are created based on thresholding a continuous measure (e.g., patients vs. controls or median split), when groups are defined exogenously (e.g., treatment vs. control groups, or male vs. female), and how the observed effect sizes are further affected by differences in measurement reliability and between-subject variance between the groups. We provide a set of equations for calculating attenuation effects across these scenarios. This has important implications for biomarker research and clinical translation, as well as any other area of research that relies on group comparisons to inform policy and real-world applications.

Indexed as

clinical translationeffect size attenuationgroup differencesgroup effectsindividual differencesmeasurement reliabilityreliability paradoxtest-retest reliability

Identifiers

PMID41169915
PMCPMC12568607

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.